Tetramethylpyrazine (TMP) protects cerebral neurocytes and inhibits glioma by down regulating chemokine receptor CXCR4 expression

Cancer Letters

Volumn 336, Issue 2, 2013, Pages 281-289

  Chen, Zhao ^a   Pan, Xueke ^a   Georgakilas, Alexandros G ^b,c   Chen, Pei ^a   Hu, Huan ^a   Yang, Ying ^a   Tian, Sijia ^a   Xia, Lei ^a   Zhang, Jing ^a   Cai, Xiaoxiao ^a   Ge, Jian ^a   Yu, Keming ^a   Zhuang, Jing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b EAST CAROLINA UNIVERSITY   (United States)

^c NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

C6 glioma cells; CXCR4; Rat cerebral neurocytes; Tetramethylpyrazine (TMP)

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GLUTAMIC ACID; HYDROGEN PEROXIDE; PLERIXAFOR; TETRAMETHYLPYRAZINE;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BRAIN NERVE CELL; CALCIUM CELL LEVEL; CANCER INHIBITION; CELL SURVIVAL; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; GLIOMA; IMMUNOFLUORESCENCE; IN VITRO STUDY; MIGRATION INHIBITION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CALCIUM; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CXCL12; DOWN-REGULATION; GLIOMA; HYDROGEN PEROXIDE; NEURONS; PYRAZINES; RATS; RECEPTORS, CXCR4;

RATTUS;

EID: 84879784031     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.03.015     Document Type: Article

References (44)

1. Claes A., Idema A.J., Wesseling P. Diffuse glioma growth: a guerilla war. Acta Neuropathol. 2007, 114:443-458.
2. Yang I., Aghi M.K. New advances that enable identification of glioblastoma recurrence. Nat. Rev. Clin. Oncol. 2009, 6:648-657.
3. Pang P.K., Shan J.J., Chiu K.W. Tetramethylpyrazine, a calcium antagonist. Planta Med. 1996, 62:431-435.
4. You J.M., Zhang Z.G., Lin C., Ji Y.X. Ischemic stroke and the regulation of syndrome of traditional Chinese medicine compound efficacy TMP combined. Chin. Archives of Tradit. Chin. Med. 2010, 28:2666-2668.
5. Tang Z.Y., Wang S.L., Lin Y. Progress in protective effects of tetramethylpyrazine on diabetes complications in nervous system and possible mechanisms. Chin. J. Pharmacol. Toxicol. 2011, 25:114-118.
6. Chen Y., Liu M. Systemic evaluation of Security of ligustrazine for treatment of cerebral infarction. Chin. J. Clin. Rehab. 2004, 8:1299-1301.
7. Yang X.G., Jiang C. Ligustrazine as a salvage agent for patients with relapsed or refractory non-Hodgkin's lymphoma. Chin. Med. J. (Engl.) 2010, 123:3206-3211.
8. Yang Z., Zhang Q., Ge J., Tan Z. Protective effects of tetramethylpyrazine on rat retinal cell cultures. Neurochem. Int. 2008, 52:1176-1187.
9. Liang Y., Yang Q.H., Yu X.D., Jiang D.M. Additive effect of tetramethylpyrazine and deferoxamine in the treatment of spinal cord injury caused by aortic cross-clamping in rats. Spinal Cord 2011, 49:302-306.
10. Li S.Y., Jia Y.H., Sun W.G., Tang Y., An G.S., Ni J.H., Jia H.T. Stabilization of mitochondrial function by tetramethylpyrazine protects against kainate-induced oxidative lesions in the rat hippocampus. Free Radical Biol. Med. 2010, 48:597-608.
11. Bao Z.J., Xia C.L. Protective effects of ligustrazine on glutamate-induced neurotoxicity in cultured hippocampal neurons. J. Xian Jiaotong Univ. (Med. Sci.) 2009, 30:423-425.
12. Hu J.C., Li Q.Q. Effect of tetramethypyrazine on the proliferation and apoptosis of lung cancer cell line of a549 and its mechanism. Med. J. Wuhan Univ. 2010, 3(19-20):50-51.
13. Lu X.M., Wang Z., Chen J.S.X.B. Tetramethylpyrazine induced expression of iNOS and NO to inhibit lung metastasis of melanoma bearing mice. Chin. J. Mod. Med. 2006, 16:3208-3210.
14. Hua Z.H., Zhou Y.H. TMP inhibits the proliferation of gastric carcinoma cells and endothelial cells. J Changchun Univ. Tradit. Chin. Med. 2009, 25:20-22.
15. Fu Y.S., Lin Y.Y., Chou S.C., Tsai T.H., Kao L.S., Hsu S.Y., Cheng F.C., Shih Y.H., Cheng H., Fu Y.Y., Wang J.Y. Tetramethylpyrazine inhibits activities of glioma cells and glutamate neuro-excitotoxicity: potential therapeutic application for treatment of gliomas. Neurol. Oncol. 2008, 10:139-152.
16. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., McClanahan T., Murphy E., Yuan W., Wagner S.N., Barrera J.L., Mohar A., Verastegui E., Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
17. Zhou Y., Larsen P.H., Hao C., Yong V.W. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J. Biol. Chem. 2002, 277:49481-49487.
18. Kioi M., Vogel H., Schultz G., Hoffman R.M., Harsh G.R., Brown J.M. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J. Clin. Invest. 2010, 120:694-705.
19. Schulte A., Gunther H.S., Phillips H.S., Kemming D., Martens T., Kharbanda S., Soriano R.H., Modrusan Z., Zapf S., Westphal M., Lamszus K. A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target. Glia 2011, 59:590-602.
20. Kasemeier-Kulesa J.C., McLennan R., Romine M.H., Kulesa P.M., Lefcort F. CXCR4 controls ventral migration of sympathetic precursor cells. J. Neurosci. 2010, 30:13078-13088.
21. Li M., Ransohoff R.M. Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog. Neurobiol. 2008, 84:116-131.
22. Bajetto A., Bonavia R., Barbero S., Piccioli P., Costa A., Florio T., Schettini G. Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J. Neurochem. 1999, 73:2348-2357.
23. Zheng J., Ghorpade A., Niemann D., Cotter R.L., Thylin M.R., Epstein L., Swartz J.M., Shepard R.B., Liu X., Nukuna A., Gendelman H.E. Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: implications for human immunodeficiency virus type 1-associated dementia. J. Virol. 1999, 73:8256-8267.
24. Zheng J., Thylin M.R., Ghorpade A., Xiong H., Persidsky Y., Cotter R., Niemann D., Che M., Zeng Y.C., Gelbard H.A., Shepard R.B., Swartz J.M., Gendelman H.E. Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J. Neuroimmunol. 1999, 98:185-200.
25. Limatola C., Giovannelli A., Maggi L., Ragozzino D., Castellani L., Ciotti M.T., Vacca F., Mercanti D., Santoni A., Eusebi F. SDF-1 alpha-mediated modulation of synaptic transmission in rat cerebellum. Eur. J. Neurosci. 2000, 12:2497-2504.
26. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., Volterra A. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 2001, 4:702-710.
27. Felszeghy K., Banisadr G., Rostene W., Nyakas C., Haour F. Dexamethasone downregulates chemokine receptor CXCR4 and exerts neuroprotection against hypoxia/ischemia-induced brain injury in neonatal rats. Neuroimmunomodulation 2004, 11:404-413.
28. Calderon T.M., Eugenin E.A., Lopez L., Kumar S.S., Hesselgesser J., Raine C.S., Berman J.W. A role for CXCL12 (SDF-1 alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. J. Neuroimmunol. 2006, 177:27-39.
29. Yu K., Chen Z., Pan X., Yang Y., Tian S., Zhang J., Ge J., Ambati B., Zhuang J. Tetramethylpyrazine-mediated suppression of C6 gliomas involves inhibition of chemokine receptor CXCR4 expression. Oncol. Rep. 2012, 28:955-960.
30. Chen Z., Pan X.K., Yu K., Kaminski J.M. J Zhuang, Effects of tetramethylpyrazine on human retinoblastoma cell line SO-RB50 and its mechanisms. New Med. 2012, 43:376-379.
31. Ragozzino D., Renzi M., Giovannelli A., Eusebi F. Stimulation of chemokine CXC receptor 4 induces synaptic depression of evoked parallel fibers inputs onto Purkinje neurons in mouse cerebellum. J. Neuroimmunol. 2002, 127:30-36.
32. Callewaere C., Banisadr G., Desarménien M.G., Mechighel P., Kitabgi P., Rostène W.H., Mélik Parsadaniantz S. The chemokine SDF-1/CXCL12 modulates the firing pattern of vasopressin neurons and counteracts induced vasopressin release through CXCR4. Proc. Natl. Acad. Sci. USA 2006, 103:8221-8226.
33. Rubin J.B., Kung A.L., Klein R.S., Chan J.A., Sun Y., Schmidt K., Kieran M.W., Luster A.D., Segal R.A. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc. Natl. Acad. Sci. USA 2003, 100:13513-13518.
34. Yang L., Jackson E., Woerner B.M., Perry A., Worms D.P., Rubin J.B. Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo. Cancer Res. 2007, 67:651-658.
35. Nervi B., Ramirez P., Rettig M.P., Uy G.L., Holt M.S., Ritchey J.K., Prior J.L., Piwnica-Worms D., Bridger G., Ley T.J., DiPersio J.F. Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. Blood 2009, 113:6206-6214.
36. Lazarini F., Tham T.N., Casanova P., Arenzana-Seisdedos F., Dubois-Dalcq M. Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. Glia 2003, 42:139-148.
37. Yu K., Zhuang J., Kaminski J.M., Ambati B., Gao Q., Ma P., Liao D., Li F., Liu X., Ge J. CXCR4 down-regulation by small interfering RNA inhibits invasion and tubule formation of human retinal microvascular endothelial cells. Biochem. Biophys. Res. Commun. 2007, 358:990-996.
38. Ohtani Y., Minami M., Kawaguchi N., Nishiyori A., Yamamoto J., Takami S., Satoh M. Expression of stromal cell-derived factor-1 and CXCR4 chemokine receptor mRNAs in cultured rat glial and neuronal cells. Neurosci. Lett. 1998, 249:163-166.
39. Cali C., Bezzi P. CXCR4-mediated glutamate exocytosis from astrocytes. J. Neuroimmunol. 2010, 224:13-21.
40. Liang Z., Yoon Y.H., Votaw J., Goodman M.M., Williams L., Shim H. Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res. 2005, 65:967-971.
41. Gunn M.D., Tangemann K., Tam C., Cyster J.G., Rosen S.D., Williams L.T. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc. Natl. Acad. Sci. USA 1998, 95:258-263.
42. Wang J.D., Ou T.T., Wang C.J., Chang T.K., Lee H.J. Platelet apoptosis resistance and increased CXCR4 expression in pediatric patients with chronic immune thrombocytopenic purpura. Thromb. Res. 2010, 126:311-318.
43. Curiel T.J. Tregs and rethinking cancer immunotherapy. J. Clin. Invest. 2007, 117:1167-1174.
44. McCandless E.E., Wang Q., Woerner B.M., Harper J.M., Klein R.S. CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:8053-8064.